A major advance in cancer investigation is occurring with the use of VHH fragments to reactivate dysfunctional p53. This vital malignant suppressor protein is frequently disabled in several forms of malignancies, https://wisesocialsmedia.com/story7482367/mini-antibodies-restore-p53-a-potential-approach-for-malignant-treatment